Focal Segmental Glomerulosclerosis 2 has an emerging clinical trial program, driven by drug treatment.
Recruiting
Active Trials
Trials often recruit across multiple countries, so totals exceed the trial count.
Stay informed about clinical trials for Focal Segmental Glomerulosclerosis 2.
Follow this disease to get updates when trials open, close, or change status.
Already have an account? Sign in to manage your watchlists.
Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.
Last sync: March 20, 2026 at 6:45 PM